Stock CLAS.H CLARITAS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Claritas Pharmaceuticals, Inc.

Equities

CLAS.H

CA1806342061

End-of-day quote Toronto S.E.
Other stock markets
 18:00:00 2022-07-18 EDT 		5-day change 1st Jan Change
0.025 CAD -16.67% Intraday chart for Claritas Pharmaceuticals, Inc. -.--% -.--%
2021 Claritas Pharmaceuticals : Updates Proposed Financing with Obsidian, Receives Australian Tax Credit, Starts Phase 1 Study of R-107 MT
2021 Claritas Pharmaceuticals, Inc. Announces Data from Study Demonstrating Effectiveness of Nitric Oxide in Patients with Severe Covid-19 Pneumonia as Validation of the Company’s Nitric Oxide-Releasing Compound, R-107 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
CLARITAS PHARMACEUTICALS, INC.
Other Biotechnology & Medical Research
-16.67%-.--%-.--%-.--%-97.22% 687K - - -

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. CLAS.H Stock
  4. Charts Claritas Pharmaceuticals, Inc.
  5. Comparison Chart